Effects of propofol intravenous general anesthesia and inhalational anesthesia on T-lymphocyte activity after breast cancer surgery: A meta-analysis

Daqi Sun,Kunyue Li,Ziqi Chai,Lijuan Wang,Shimin Gu,Na Sun,Yu Zhang,Yuxia Wang,Tao Wang

DOI: https://doi.org/10.4103/jrms.jrms_336_23

2024-02-23

Journal of Research in Medical Sciences

Abstract:Breast cancer has the highest incidence in women, accounting for 30% of all cancers in the female population, and the incidence of infectious breast cancer in women increased slightly from 2007 to 2016, increasing by 0.3% per year. [ 1 ] Surgical removal of solid tumors is the most common and effective form of treatment, and the usual anesthesia for breast surgery is general anesthesia, including intravenous propofol anesthesia and inhalation anesthesia. However, surgery and anesthesia also pose several side risks to patients, which can produce intense stress responses, induce immunosuppression, and cause cancer to recur or metastasize. Immunocompromise has no benefits to the recovery of the disease and long-term survival in breast cancer patients, whereas anesthesia and surgery will lead to a 3–4 times increase in the rate of tumor metastasis in tumor patients. [ 2 ] Therefore, it is very important to explore how to choose a reasonable anesthesia method to appropriately reduce the immune suppression caused by surgery and anesthesia.

medicine, general & internal